11 employees
Ancora Biotech LLC is a privately held company supporting the clinical development of three multi-specific antibodies.
2021
$60M
from 2 investors over 2 rounds
Ancora Biotech raised $60M on June 18, 2022
Investors: Lightspeed Venture Partners and S.R. One Ltd